Cyril Amarchand Mangaldas Advises Zenex Animal Health India Private Limited (Zenex) In 100% Acquisition Of Ayurvet Limited (Ayurvet).

Cyril Amarchand Mangaldas Advises On IPO Of India Shelter Finance Corporation Limited.

India – ‘Technical Breach’ Not A Contravention Of Section 39 Of The Patents Act?

India – Court Interprets “Known Substance” In Respect Of Section 3(D) Of The Patents Act.

India – Substantial Issues In Defining “Substantially The Whole Of The Undertaking”.

India – Summary Of The Draft Trade Marks (1st Amendment) Rules, 2024.

India – Declaration Of Dividend: Interplay Of Law And Business Dynamics.

- Bharat Vasani - Cyril Amarchand Mangaldas,

India – Cause Of Action For A Writ Petition In Patent Suit Stands Independent Of “Appropriate Patent Office” Determination Under Patent Rules.

India – Navigating Taxation Of Capital Contributions In A Sea Of Anti-Avoidance Provisions.

India – AKP Banking & Finance Digest- January 29, 2024.

- Anuroop Omkar - AK & Partners,

Cyril Amarchand Mangaldas Advised Direct Selling Acquisition Corporation  “DSAQ” In Facilitating Its Definitive Business Combination Agreement With  FlyBlade (India) Private Limited .

Cyril Amarchand Mangaldas Advised Premji Investment In Its Proposed 100% Exit From Organic India Private Limited.